Skip to main content
. 2010 Feb 10;10:39. doi: 10.1186/1471-2407-10-39

Table 6.

Three-year survival in the 210 patients with N2-3 disease treated with or without concurrent chemotherapy

No concurrent chemotherapy With concurrent chemotherapy P Value
DFS 74.6 81.7 0.24
MFS 79.3 84 0.22
OS 85.8 89.3 0.71